According to the National Cancer Institute, prostate cancer represents one in four male cancers or 50,400 new cases in France in 2015. It remains rare until the age of 50, then the incidence increases with age. It is a cancer with a good prognosis, especially if it is diagnosed at a stage where it is still localized (without metastases). Various treatments are possible, the choice of which is sometimes discussed with the patient. A study has just shown that fifteen years after diagnosis there are no major differences in mortality between treatments.
These results are published New England Journal of Medicinebased on medical data from around 82,000 Britons aged 50 to 69 who had a PSA test (a measure of a specific prostate protein that, when high, can signal an abnormality such as cancer) between 1999 and 2009. 1,610 diagnosed with localized prostate cancer admitted that their treatment should be…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.